Valeant Pharma (VRX) Reports Q2 EPS of $1.91
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Form 4 Valeant Pharmaceuticals For: Jul 29 Filed by: Chai-Onn Robert Roswell
July 30, 2014 5:19 PM EDThttp://archive.fast-edgar.com/20140730/ATKZO222Z22L3272222T22Z2J5OKZZ22AZ62 Filed on: July 30, 2014... More
